DB2115 tertahydrochloride |
| Catalog No.GC63364 |
L-푸코스 유사체인 2-데옥시-2-플루오로-L-푸코스는 푸코실화 억제제입니다. 2-Deoxy-2-fluoro-L-fucose는 포유류 세포에서 GDP-fucose의 de novo 합성을 억제합니다. 푸코실화는 많은 인간 암의 진행에 대해 비교적 잘 정의된 바이오마커입니다. 예를 들어, 췌장 및 간세포 암종.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1366126-19-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
[1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
Average Rating: 5 (Based on Reviews and 15 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *